This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
AB1_HIV_MALIGNANT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
23 |
4. Check minimum number of eventsNone |
23 |
5. Include endpointsNone |
23 |
6. Filter based on genotype QC (FinnGen only) |
23 |
Control definitions (FinnGen only)
- Control exclude
- AB1_HIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
based on the number of shared cases.
Similar with more cases:
- Human immunodeficiency virus [HIV] disease
- Certain infectious and parasitic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 198 | 56 | 133 |
| Only index persons | 156 | 54 | 102 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 41.73 | 36.98 | 44.02 |
| Only index persons | 41.45 | 36.98 | 43.82 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 23 | 5 | 18 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | 42.00 | 43.18 | 41.67 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
18
0
+∞
22.65
4.1
0.0
%
20.4
—
—
5
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
17
43
12.15
6.97
3.1
3.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
18
57
10.80
6.24
15.9
8.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
5
0
+∞
5.39
4.8
0.0
g/mol
19.2
—
—
5
0
(3013762) Body weight Measured
5
0
+∞
5.39
1.0
0.0
—
—
—
0
0
(3015736) pH of Urine
18
68
8.50
5.17
3.4
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
18
72
7.83
4.82
4.4
3.2
e6/l
4.9
17.3
—
8
59
(3019832) Treponema pallidum Ab [Presence] in Serum
9
13
10.53
4.70
2.0
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
7
13.61
4.34
2.6
1.9
mg/l
1.3
1.6
—
7
7
(3052851) Hemolysis interference index of Serum or Plasma
7
7
13.61
4.34
3.4
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
5
15.48
4.00
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
29
4.42
2.58
1.1
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
9
33
3.81
2.25
1.0
1.4
nmol/l
21.7
22.0
—
9
26
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
21
4.32
2.17
3.1
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
11
5.47
2.05
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
18
4.12
1.89
3.2
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
11
52
3.14
1.80
1.5
1.8
pmol/l
99.7
103.5
—
6
28
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7
26
3.41
1.75
1.1
2.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
17
209
0.29
1.63
16.0
12.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
17
3.45
1.44
1.4
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
0
33
0.00
1.28
0.0
1.2
—
6.4
—
0
14
(3026008) Bacteria identified in Urine by Culture
7
30
2.90
1.26
1.7
2.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
7
33
2.60
1.18
2.7
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
12
73
2.35
1.09
2.8
3.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
22
2.61
1.09
1.2
2.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
22
2.61
1.09
1.2
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
6
27
2.64
1.02
1.8
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
10
61
2.13
0.86
2.8
2.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
0
25
0.00
0.85
0.0
8.8
—
103.4
—
0
25
(3007853) Bacteria identified in Skin by Aerobe culture
5
23
2.49
0.82
2.2
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
5
25
2.27
0.78
1.6
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
11
73
1.97
0.74
1.4
1.7
—
—
—
0
0
(4010399)
0
21
0.00
0.63
0.0
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
17
141
1.78
0.57
3.2
3.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
7
47
1.70
0.54
2.7
7.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
11
141
0.58
0.52
4.2
3.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
9
65
1.63
0.47
1.2
2.8
nmol/l
59.1
74.3
—
9
59
(3039443) Prostate specific Ag panel - Serum or Plasma
0
15
0.00
0.43
0.0
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
14
159
0.70
0.32
4.5
3.3
u/l
82.5
56.7
0.68
14
152
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
0
11
0.00
0.22
0.0
12.4
—
0.6
—
0
11
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
0
11
0.00
0.22
0.0
12.4
—
1.3
—
0
11
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
0
11
0.00
0.22
0.0
2.8
—
2.3
—
0
11
(3020891) Body temperature
0
11
0.00
0.22
0.0
4.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
0
10
0.00
0.22
0.0
3.0
—
0.8
—
0
10
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
0
10
0.00
0.22
0.0
2.7
—
50.0
—
0
10
(3001019) Free T4 and TSH panel - Serum or Plasma
0
10
0.00
0.22
0.0
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
7
56
1.36
0.21
1.4
5.8
—
7.4
—
0
12
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
13
0.00
0.21
0.0
2.5
—
0.1
—
0
13
(1002224) Polysomnography panel
0
14
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
14
0.00
0.21
0.0
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5
67
0.68
0.20
3.8
3.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
9
78
1.25
0.19
6.6
9.3
mmol/l
1.2
1.2
—
9
67
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
7
85
0.75
0.19
3.6
4.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
6
56
1.10
0.09
3.5
6.0
mmol/l
2.6
2.3
—
6
51
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
7
63
1.16
0.09
1.9
1.7
u/l
89.7
128.5
—
7
58
(40768443) Skin Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
3.8
—
4.2
—
0
5
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
6
63
0.94
0.00
2.2
2.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.3
—
0.0
—
0
6
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5
50
1.00
0.00
3.8
2.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
10.9
—
0
6
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4034850)
0
8
0.00
0.00
0.0
9.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4062490)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
11.0
—
18.4
—
0
5
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(4268621)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_HIV_MALIGNANT and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_HIV_MALIGNANT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_HIV_MALIGNANT – Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data